Necessity of appendectomy for mucinous borderline ovarian tumors. Systematic review.
Cosyns S, De Sutter P, Tournaye H, Polyzos NP.
Arch Gynecol Obstet. 2016 Nov;294(6):1283-1289. doi: 10.1007/s00404-016-4174-y. Epub 2016 Aug 17.
Inflammatory myofibroblastic tumor of the small intestine mimicking acute appendicitis: a case report and review of the literature.
Oeconomopoulou A, de Verney Y, Kanavaki K, Stefanaki K, Pavlakis K, Salakos C.
J Med Case Rep. 2016 Apr 19;10:100. doi: 10.1186/s13256-016-0880-0.
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG.
J Clin Oncol. 2012 Dec 10;30(35):4344-51. doi: 10.1200/JCO.2012.43.8085. Epub 2012 Nov 13.
The role of appendectomy as part of the treatment of a mucinous borderline ovarian tumor.
Cosyns S, Polyzos NP, Carprieaux M, Tournaye H, De Sutter P.
Eur J Gynaecol Oncol. 2016;37(2):167-70.
Mucinous borderline tumours of the ovary and the appendix: a retrospective study and overview of the literature.
Kleppe M, Bruls J, Van Gorp T, Massuger L, Slangen BF, Van de Vijver KK, Kruse AJ, Kruitwagen RF.
Gynecol Oncol. 2014 May;133(2):155-8. doi: 10.1016/j.ygyno.2014.02.013. Epub 2014 Feb 16.
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial.
Heinemann V, von Weikersthal LF, Decker T, Kiani A, Kaiser F, Al-Batran SE, Heintges T, Lerchenmüller C, Kahl C, Seipelt G, Kullmann F, Moehler M, Scheithauer W, Held S, Miller-Phillips L, Modest DP, Jung A, Kirchner T, Stintzing S.
Br J Cancer. 2021 Feb;124(3):587-594. doi: 10.1038/s41416-020-01140-9. Epub 2020 Nov 6.
Proposal of "borderline resectable" colorectal liver metastases based on analysis of risk factors for early surgical failure.
Ninomiya M, Itoh S, Takeishi K, Toshima T, Yoshiya S, Morita K, Minagawa R, Iguchi T, Oki E, Yoshizumi T.
Surg Today. 2025 Mar;55(3):425-433. doi: 10.1007/s00595-024-02920-z. Epub 2024 Aug 19.
Histopathological diagnosis of ulcerative colitis-associated neoplasia.
Kawachi H.
Dig Endosc. 2019 Apr;31 Suppl 1:31-35. doi: 10.1111/den.13387.
Practice-changing clinical trials in radiation oncology for gastrointestinal malignancies in 2021-2023.
Boustani J, Huguet F, Vendrely V.
Cancer Radiother. 2023 Dec;27(8):768-777. doi: 10.1016/j.canrad.2023.08.001. Epub 2023 Oct 26.
Loss of SATB2 expression correlates with cytokeratin 7 and PD-L1 tumor cell positivity and aggressiveness in colorectal cancer.
Hrudka J, Matěj R, Nikov A, Tomyak I, Fišerová H, Jelínková K, Waldauf P.
Sci Rep. 2022 Nov 9;12(1):19152. doi: 10.1038/s41598-022-22685-0.
